- Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients
-
Htun YY, Than NN, Swe HK
- KMID: 2503779
- Korean J Transplant.
- 2020 Mar;34(1):24-30.
- doi: 10.4285/kjt.2020.34.1.24
Background: Renal transplant is an effective treatment option for end-stage kidney disease and tacrolimus is one of the most commonly used immunosuppressant drugs in renal transplant patients. Tacrolimus is a... -
- CITED
-
- Close
- SHARE
-
- Close
